secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001193125-23-177539
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics regains compliance with Nasdaq minimum bid price requirement
-------------------------------------------------------------------------------

- Received letter from Nasdaq on June 27, 2023 confirming regained compliance with Listing Rule 5450(a)(1).
- Closing bid price was $1.00 or greater for 10 consecutive business days from June 12 to June 26, 2023.
- Previously notified of deficiency on Dec 30, 2022; compliance deadline was June 28, 2023.
- Nasdaq considers the compliance matter closed; no further action required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/0001193125-23-177539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/d510150d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-177539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer